루닛 둜고

루닛 (328130) μ£Όκ°€ 및 μ’…λͺ© 정보

루닛 μ£Όκ°€ 및 핡심 정보

ν˜„μž¬κ°€ 및 핡심 투자 정보
ν•­λͺ© κ°’
ν˜„μž¬κ°€ 10,570 원
λ³€λ™λŸ‰ β–Ό 530 원
변동λ₯  -4.77%
κΈ°μ€€ μ‹œκ°
거래 ꡬ뢄 μ •κ·œμž₯
μ‹œμž₯ KOSDAQ
κ±°λž˜μ†Œ KRX Β· NXT 거래 κ°€λŠ₯
μ‹œκ°€ 10,930 원
κ³ κ°€ 11,040 원
μ €κ°€ 10,520 원
52μ£Ό λ²”μœ„ 8,180 원 ~ 24,550 원
κ±°λž˜λŸ‰ 563,147
κ±°λž˜λŒ€κΈˆ 6,007,030,750 원
μ‹œκ°€μ΄μ•‘ 8,264얡원
PER -25.25λ°°
PBR 8.75λ°°
EPS -762.9625 원
μ—…μ’… μ†Œν”„νŠΈμ›¨μ–΄

일별 μ£Όκ°€

κ³Όκ±° 일별 μ£Όκ°€ 정보
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
2026.09.17 8,250 8,370 8,210 8,290 255,109 2,111,852,705
2026.09.18 9,290 9,350 8,720 8,770 1,314,991 11,786,886,370
2026.09.21 9,860 10,570 9,320 10,240 2,300,527 22,796,092,470
2026.09.22 10,040 10,040 9,480 9,590 854,510 8,330,690,180
2026.09.23 9,850 10,080 9,750 9,870 710,617 7,037,736,835
2026.09.28 11,360 12,490 11,050 11,230 4,821,459 56,945,087,925
2026.09.29 11,570 12,000 11,100 11,820 1,529,049 17,824,737,935
2026.09.30 11,610 11,610 10,750 10,800 1,133,787 12,444,239,550
2026.10.01 10,740 11,140 10,450 11,130 719,159 7,789,737,815
2026.10.02 10,930 11,040 10,520 10,570 563,147 6,007,030,750

νšŒμ‚¬ 정보

κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅°
KOSDAQ 106μœ„ 74,458,180 8.02% IT/ICT μ†Œν”„νŠΈμ›¨μ–΄

κΈ°μ—… κ°œμš”

루닛은 2013λ…„ 08μ›” 23일 섀립 λ˜μ—ˆμœΌλ©°, μƒν˜Έλ₯Ό ν΄λ””μ—μ„œ ν˜„μž¬μ˜ μ£Όμ‹νšŒμ‚¬ λ£¨λ‹›μœΌλ‘œ λ³€κ²½, AIν—¬μŠ€μΌ€μ–΄ 사업을 μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ Lunit INSIGHT, Lunit SCOPE μ œν’ˆ νŒλ§€μ—μ„œ λ°œμƒν•˜κ³  μžˆλ‹€. λ‹Ήμ‚¬λŠ” λ”₯λŸ¬λ‹ κΈ°μˆ μ„ 톡해 μΈκ°„μ˜ μ‹œκ°μ  ν•œκ³„λ₯Ό λ³΄μ™„ν•˜λŠ” νŒλ… 보쑰 μ†”λ£¨μ…˜μ„ κ°œλ°œν•˜μ—¬ μƒμš©ν™”ν•˜μ˜€μœΌλ©°, μ œμ•½νšŒμ‚¬, μž„μƒμ‹œν—˜ μ „λ¬ΈκΈ°κ΄€, 진단검사 μˆ˜νƒκΈ°κ΄€ 등을 λŒ€μƒμœΌλ‘œ ν•˜λŠ” μ—°κ΅¬μš© 판맀λ₯Ό 톡해 μ„±μž₯ 동λ ₯을 ν™•λ³΄ν•˜κ³ , 의료기기 ν—ˆκ°€λ₯Ό νšλ“ν•˜μ—¬ μž„μƒμš© 판맀둜 μ‹œμž₯을 ν™•λŒ€ν•  μ˜ˆμ •μ΄λ‹€.

κ΄€λ ¨ ν…Œλ§ˆ

  • AI : λ”₯λŸ¬λ‹ 기반 의료 인곡지λŠ₯(AI) 업체 λ”₯λŸ¬λ‹ κΈ°μˆ μ„ 톡해 μΈκ°„μ˜ μ‹œκ°μ  ν•œκ³„λ₯Ό λ³΄μ™„ν•˜λŠ” νŒλ… 보쑰(AIassisted detection) μ†”λ£¨μ…˜μ„ κ°œλ°œν•˜μ—¬ μƒμš©ν™”ν–ˆμœΌλ©°, μ£Όμš” μ œν’ˆ 및 μ„œλΉ„μŠ€λ‘œλŠ” μ•” 진단 κ΄€λ ¨ μ˜μƒ νŒλ… 보쑰 μ†”λ£¨μ…˜μΈ Lunit INSIGHT와 μ•” 치료 κ΄€λ ¨ 이미징 λ°”μ΄μ˜€λ§ˆμ»€ μ†”λ£¨μ…˜μΈ Lunit SCOPE 등이 있음
  • 의료기기 : κΈ€λ‘œλ²Œ μ˜λ£ŒκΈ°κ΄€ 3,600κ³³ μ΄μƒμ—μ„œ AI μ˜μƒ μ†”λ£¨μ…˜ μ‚¬μš©
  • AI의료 : μ•” 진단 μ˜μƒ νŒλ… AI와 μœ λ°©μ•” 검진 μ†Œν”„νŠΈμ›¨μ–΄ 보유

AI예츑

AIμ˜ˆμΈ‘κΈ°λŠ” 이 μ’…λͺ©μ„ κ°•λ ₯맀도 Β· 맀도 Β· 쀑립 Β· 맀수 Β· κ°•λ ₯맀수 둜 μ˜ˆμΈ‘ν–ˆμ–΄μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ μ˜ˆμƒ μ£Όκ°€ μ‹œλ‚˜λ¦¬μ˜€μ™€ AI의 투자의견, λͺ©ν‘œΒ·μ†μ ˆκ°€, AIκ°€ μ°Έκ³ ν•œ 차트 νŒ¨ν„΄λ“€μ„ 확인할 수 μžˆμŠ΅λ‹ˆλ‹€.

μ§€ν‘œλΆ„μ„

수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ€ 이 μ’…λͺ©μ„ 맀수 Β· 맀도 Β· 보유 Β· 관망 μ€‘μ΄μ—μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ 수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ˜ 맀맀 μ‹œμ μ„ ν™•μΈν•˜κ³  λ‹€μŒ μ‹ ν˜Έλ₯Ό μ•Œλ¦ΌμœΌλ‘œ λ°›μ•„λ³Ό 수 μžˆμŠ΅λ‹ˆλ‹€.

μ΅œμ‹  κ΄€λ ¨ λ‰΄μŠ€

[λŒ€μ „=팍슀경제TV] κ±΄μ–‘λŒ€μ˜λ£Œμ›μ€ 의료 인곡지λŠ₯ κΈ°μ—… γˆœλ£¨λ‹›κ³Ό 의료 νŠΉν™” νŒŒμš΄λ°μ΄μ…˜ λͺ¨λΈ 고도화λ₯Ό μœ„ν•œ μ—…λ¬΄ν˜‘μ•½μ„ ν–ˆμŠ΅λ‹ˆλ‹€. ν˜‘μ•½μ‹μ€ 1일 μ˜€μ „ 10μ‹œ κ±΄μ–‘λŒ€ν•™κ΅μ˜λ£Œμ› 연ꡬ2동 λŒ€νšŒμ˜μ‹€μ—μ„œ μ—΄λ ΈμœΌλ©° κΉ€μš©μ„ μ˜λ£Œμ •λ³΄μ›μž₯κ³Ό μ„œλ²”μ„ λŒ€ν‘œμ΄μ‚¬λ₯Ό λΉ„λ‘―ν•΄ μ–‘ κΈ°κ΄€ κ΄€κ³„μžλ“€μ΄ μ°Έμ„ν–ˆμŠ΅λ‹ˆλ‹€. 이번 ν˜‘μ•½μ€ 의료 νŠΉν™” FMκ³Ό νŠΉν™”λ°μ΄ν„°λ₯Ό κ³ λ„ν™”ν•˜κ³  이λ₯Ό μ§„λ£Œμ™€ 병원 운영 μ „λ°˜μ— ν™œμš©ν•΄ ν™˜μž 건강 증진과 의료 ν˜μ‹ μ— κΈ°μ—¬ν•˜κ³ μž μΆ”μ§„λœ κ²ƒμž…λ‹ˆλ‹€. κ±΄μ–‘λŒ€μ˜λ£Œμ›μ€ 읡λͺ…ν™”Β·λΉ„μ‹λ³„ν™”λœ μž„μƒλ°μ΄ν„°λ₯Ό μ œκ³΅ν•˜κ³  μž„μƒ 검증과 ν˜„μž₯ 싀증을 λ‹΄λ‹Ήν•˜λ©° 루닛은

루닛은 이달 23일뢀터 27μΌκΉŒμ§€ 슀페인 λ§ˆλ“œλ¦¬λ“œμ—μ„œ μ—΄λ¦¬λŠ” '2026 μœ λŸ½μ’…μ–‘ν•™νšŒ(ESMO)'μ—μ„œ AI λ°”μ΄μ˜€λ§ˆμ»€ ν”Œλž«νΌ '루닛 μŠ€μ½”ν”„'λ₯Ό ν™œμš©ν•œ μ—°κ΅¬μ΄ˆλ‘ 5νŽΈμ„ λ°œν‘œν•œλ‹€κ³  1일 λ°ν˜”λ‹€.루닛은 이번 ν•™νšŒμ—μ„œ μΌλ³Έμ—μ„œ μ‹€μ‹œλœ λΉ„μ†Œμ„Έν¬νμ•” ν™˜μžμ˜ 수술 검체λ₯Ό ν™œμš©ν•œ λŒ€κ·œλͺ¨ PD-L1 평가 연ꡬλ₯Ό κ³΅κ°œν•œλ‹€. λ©΄μ—­ν•­μ•”μ œ 치료 κ²°μ •μ˜ μ£Όμš” 기쀀인 PD-L1 λ°œν˜„ 정도λ₯Ό 각각 루닛 μŠ€μ½”ν”„μ™€ 병리과 μ „λ¬Έμ˜κ°€ 직접 ν‰κ°€ν•œ κ²°κ³Όκ°€ μ–Όλ§ˆλ‚˜ μΌμΉ˜ν•˜λŠ”μ§€ λΉ„κ΅ν•œ 연ꡬ닀.λ˜ν•œ ν”„λž‘μŠ€ μ•” μ „λ¬ΈκΈ°κ΄€ ICOκ°€ μ§„ν–‰ν•œ ν”„λ‘œμ νŠΈμ— μ°Έμ—¬ν•΄, μœ λ°©μ•” HER2 뢄석을 μœ„ν•œ μ—¬λŸ¬ AI μ•Œκ³ λ¦¬μ¦˜μ„ λΉ„κ΅ν•œ 연ꡬλ₯Ό μ†Œκ°œν•œλ‹€.이밖에도 AI 기반 기질 뢄석을 톡해 췌μž₯κ΄€μ„ μ•”μ—μ„œ μ’…μ–‘ λ§₯락에 따라 λ‹¬λΌμ§€λŠ” λ‚΄ν”Όμ„Έν¬μ˜ μ˜ˆν›„μ  μ˜λ―Έμ™€ KRAS 변이 μ•„ν˜•λ³„ νŠΉμ„±μ„ λΆ„μ„ν•œ 연ꡬ λ“± 3건을 λ°œν‘œν•  μ˜ˆμ •μ΄λ‹€.루닛은 ν•™νšŒ κΈ°κ°„ μ „μ‹œμž₯에 단독 λΆ€μŠ€λ„ μš΄μ˜ν•œλ‹€. λΆ€μŠ€μ—μ„œλŠ” 루닛 μŠ€μ½”ν”„ μ œν’ˆκ΅°μ„ μ†Œκ°œν•˜κ³ , μ œν’ˆ μ‹œμ—°μ„ 톡해 AI λ°”μ΄μ˜€λ§ˆμ»€κ°€ 병리 이미지λ₯Ό λΆ„μ„ν•˜λŠ” 과정을 방문객이 직접 확인할 수 μžˆλ„λ‘ ν•  κ³„νšμ΄λ‹€.μ„œλ²”μ„ 루닛 λŒ€ν‘œλŠ” "이번 ESMO 2026μ—μ„œ

루닛(328130)이 μœ λŸ½μ’…μ–‘ν•™νšŒμ—μ„œ 인곡지λŠ₯(AI) λ°”μ΄μ˜€λ§ˆμ»€(μƒμ²΄ν‘œμ§€μž)λ₯Ό ν™œμš©ν•œ 연ꡬ성과λ₯Ό κ³΅κ°œν•œλ‹€. 루닛은 이달 23일(ν˜„μ§€μ‹œκ°„)λΆ€ν„° 27μΌκΉŒμ§€ 슀페인 λ§ˆλ“œλ¦¬λ“œμ—μ„œ μ—΄λ¦¬λŠ” β€˜2026 μœ λŸ½μ’…μ–‘ν•™νšŒ(ESMO 2026)β€™μ—μ„œ AI λ°”μ΄μ˜€λ§ˆμ»€ β€˜λ£¨λ‹› μŠ€μ½”ν”„β€™λ₯Ό ν™œμš©ν•œ

μ‹€μ ν˜„ν™©

λ§€μΆœμ•‘

κΈ°κ°„ ꡬ뢄 λ§€μΆœμ•‘ μ¦κ°€μœ¨
2025 μ—°κ°„ (YoY) 83,129,295,404 53.43%
2024 μ—°κ°„ (YoY) 54,179,663,335 116.03%
2023 μ—°κ°„ (YoY) 25,080,238,712 80.88%
2022 μ—°κ°„ (YoY) 13,865,732,000 108.85%
2026.2Q λΆ„κΈ° (QoQ) 21,813,709,916 -8.93%
2026.1Q λΆ„κΈ° (QoQ) 23,952,343,774 -9.53%
2025.4Q λΆ„κΈ° (QoQ) 26,476,422,178 35.25%
2025.3Q λΆ„κΈ° (QoQ) 19,575,722,788 9.52%

μ˜μ—…μ΄μ΅

κΈ°κ°„ ꡬ뢄 μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨
2025 μ—°κ°„ (YoY) -83,103,910,311 -22.80%
2024 μ—°κ°„ (YoY) -67,672,567,880 -60.30%
2023 μ—°κ°„ (YoY) -42,216,718,386 16.65%
2022 μ—°κ°„ (YoY) -50,650,984,000 -210.83%
2026.2Q λΆ„κΈ° (QoQ) -15,368,887,353 -13.06%
2026.1Q λΆ„κΈ° (QoQ) -13,593,188,215 31.25%
2025.4Q λΆ„κΈ° (QoQ) -19,772,798,612 8.27%
2025.3Q λΆ„κΈ° (QoQ) -21,555,812,087 -2.11%

순이읡

κΈ°κ°„ ꡬ뢄 순이읡 μ¦κ°€μœ¨
2025 μ—°κ°„ (YoY) -47,389,679,756 42.50%
2024 μ—°κ°„ (YoY) -82,420,863,344 -123.98%
2023 μ—°κ°„ (YoY) -36,798,251,578 5.93%
2022 μ—°κ°„ (YoY) -39,117,906,000 -153.09%
2026.2Q λΆ„κΈ° (QoQ) -23,557,162,142 -32.27%
2026.1Q λΆ„κΈ° (QoQ) -17,809,588,938 45.34%
2025.4Q λΆ„κΈ° (QoQ) -32,581,949,764 -279.77%
2025.3Q λΆ„κΈ° (QoQ) 18,124,554,298 151.84%

μˆœλ§€μˆ˜λŸ‰

개인: 162,179

κΈ°κ΄€: -126,352

외인: -36,734

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: 3,449,462

κΈ°κ΄€: -551,005

외인: -2,919,217

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-10-02 162,179 -126,352 -36,734
2026-10-01 -65,351 11,947 54,390
2026-09-30 457,093 -226,202 -231,448
2026-09-29 -72,476 130,762 -53,083
2026-09-28 382,496 -83,339 -300,061
2026-09-23 35,215 42,782 -75,526
2026-09-22 209,061 52,720 -267,779
2026-09-21 103,749 173,799 -279,138
2026-09-18 300,405 -30,354 -266,910
2026-09-17 -6,088 -263 6,151
2026-09-16 67,065 -2,488 -64,231
2026-09-15 -5,389 90,783 -87,353
2026-09-14 -25,147 55,526 -29,954
2026-09-11 44,887 -106,707 61,771
2026-09-10 133,805 41,919 -178,754
2026-09-09 111,609 -53,395 -56,398
2026-09-08 69,356 -20,259 -49,507
2026-09-07 103,018 -15,358 -87,473
2026-09-04 -7,716 8,366 -2,324
2026-09-03 52,531 -24,186 -28,361
2026-09-02 115,360 -75,364 -40,573

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-10-02 2,165,662 -155,663 -2,013,295
2026-10-01 2,003,483 -29,311 -1,976,561
2026-09-30 2,068,834 -41,258 -2,030,951
2026-09-29 1,611,741 184,944 -1,799,503
2026-09-28 1,684,217 54,182 -1,746,420
2026-09-23 1,301,721 137,521 -1,446,359
2026-09-22 1,266,506 94,739 -1,370,833
2026-09-21 1,057,445 42,019 -1,103,054
2026-09-18 953,696 -131,780 -823,916
2026-09-17 653,291 -101,426 -557,006
2026-09-16 659,379 -101,163 -563,157
2026-09-15 592,314 -98,675 -498,926
2026-09-14 597,703 -189,458 -411,573
2026-09-11 622,850 -244,984 -381,619
2026-09-10 577,963 -138,277 -443,390
2026-09-09 444,158 -180,196 -264,636
2026-09-08 332,549 -126,801 -208,238
2026-09-07 263,193 -106,542 -158,731
2026-09-04 160,175 -91,184 -71,258
2026-09-03 167,891 -99,550 -68,934
2026-09-02 115,360 -75,364 -40,573

μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
545,270,658,294 39.18% 60.82%

맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
μ†Œν”„νŠΈμ›¨μ–΄ [Cancer Screening] 71.85%
μš©μ—­ [Oncology] 24.38%
기타 [Oncology] 2.32%
기타 [Cancer Screening] 1.18%
기타 0.14%
μƒν’ˆ 0.13%

곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 123,578 (12.65%)

졜근 곡맀도 μž”κ³ : 1,676,306 (2.25%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2026-10-02 10,570 123,578 12.65%
2026-10-01 11,130 88,871 6.67%
2026-09-30 10,800 220,304 11.61%
2026-09-29 11,820 21,535 0.74%
2026-09-28 11,230 328,525 3.47%
2026-09-23 9,870 94,009 7.07%
2026-09-22 9,590 144,788 9.08%
2026-09-21 10,240 170,216 3.55%
2026-09-18 8,770 120,161 5.10%
2026-09-17 8,290 102,411 28.69%
2026-09-16 8,250 41,272 10.75%
2026-09-15 8,560 29,790 8.72%
2026-09-14 8,470 46,696 10.86%
2026-09-11 8,490 77,838 15.50%
2026-09-10 8,480 126,997 16.60%
2026-09-09 8,630 62,481 18.06%
2026-09-08 8,700 36,855 10.71%
2026-09-07 8,870 28,511 8.72%
2026-09-04 9,000 38,641 9.37%
2026-09-03 8,560 68,598 18.59%
2026-09-02 8,640 83,457 18.50%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2026-09-30 10,800 1,676,306 2.25%
2026-09-29 11,820 1,419,844 1.91%
2026-09-28 11,230 1,344,759 1.81%
2026-09-23 9,870 1,058,574 1.42%
2026-09-22 9,590 963,412 1.29%
2026-09-21 10,240 729,814 0.98%
2026-09-18 8,770 783,553 1.05%
2026-09-17 8,290 454,889 0.61%
2026-09-16 8,250 390,349 0.52%
2026-09-15 8,560 333,853 0.45%
2026-09-14 8,470 297,195 0.40%
2026-09-11 8,490 285,689 0.38%
2026-09-10 8,480 283,316 0.38%
2026-09-09 8,630 259,182 0.35%
2026-09-08 8,700 259,246 0.35%
2026-09-07 8,870 259,447 0.35%
2026-09-04 9,000 247,552 0.33%
2026-09-03 8,560 244,054 0.33%
2026-09-02 8,640 267,109 0.36%
2026-09-01 9,090 268,225 0.36%
2026-08-31 9,090 283,483 0.38%

μ—…μ’… λ‚΄ 비ꡐ

μ†Œν”„νŠΈμ›¨μ–΄ μ—…μ’…(79개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© ν˜„μž¬ μ’…λͺ© μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 8,264.858 1,082.23 2μœ„
PER(졜근4λΆ„κΈ°) -12.009 -11.68 68μœ„
PBR 2.499 31,480.21 9μœ„
ROE(졜근4λΆ„κΈ°) -31.353 -5.29 68μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) -99.969 -21.72 71μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) -57.007 -25.53 68μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) 169.158 76.03 9μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 831.293 3,102.93 19μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) -831.039 220.65 77μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) -473.897 165.86 77μœ„